20-F/A

AMENDMENT NO. 1

Company: Biodexa Pharmaceuticals Plc
Filed: May 28, 2019
Period of Report: December 31, 2018
Accession Number: 0001214659-19-003834

View Document ↗ View on SEC.gov ↗